![Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6602074/MediaObjects/41416_2004_Article_BF6602074_Fig2_HTML.gif)
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer
![New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | Discover Nano New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | Discover Nano](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs11671-020-3247-9/MediaObjects/11671_2020_3247_Sch3_HTML.png)
New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | Discover Nano
![CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB Martin J. Edelman, MD, Lydia. - ppt download CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB Martin J. Edelman, MD, Lydia. - ppt download](https://slideplayer.com/12149890/71/images/slide_1.jpg)
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB Martin J. Edelman, MD, Lydia. - ppt download
![CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6601851/MediaObjects/41416_2004_Article_BF6601851_Fig1_HTML.gif)
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer
![PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/83dc660dc7808a39e51189599c6720de87c99b00/6-Table2-1.png)
PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar
![Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma - Shiiya - 2021 - Thoracic Cancer - Wiley Online Library Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma - Shiiya - 2021 - Thoracic Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2a510018-17d4-4d2e-a359-d9fc6fa8c17d/tca14158-toc-0001-m.jpg?trick=1709819998703)
Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma - Shiiya - 2021 - Thoracic Cancer - Wiley Online Library
![Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6602074/MediaObjects/41416_2004_Article_BF6602074_Fig1_HTML.gif)
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer
![PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/83dc660dc7808a39e51189599c6720de87c99b00/6-Table3-1.png)
PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE
![Cancers | Free Full-Text | The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer Cancers | Free Full-Text | The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer](https://pub.mdpi-res.com/cancers/cancers-14-05064/article_deploy/html/images/cancers-14-05064-ag.png?1666765625)